Practically all taxes distort economic incentives to some extent, opines healthcare expert Alain Enthoven. But taxes on healthcare currently under consideration by the Senate Finance Committee are particularly perverse. Instead of promoting prepayment and integrated care with the right incentives-the best long term strategy for keeping coverage affordable-this policy moves us in the wrong direction.
Does Medicare make a difference?
How the Positive Deviance Initiative helps communities solve their own problems
Solutions to supply chain problems from motorcycle parts in Africa to grocery delivery and solar power in the US were shared at the Advancing Socially and Environmentally Responsible Supply Chains Conference presented by the Stanford Global Supply Chain Management Forum and the Center for Social Innovation at the Stanford Graduate School of Business.
Texting emerges as a source of confirmation for drug legitimacy.
Solutions to supply chain problems from motorcycle parts in Africa to grocery delivery and solar power in the US were shared at the Advancing Socially and Environmentally Responsible Supply Chains Conference presented by the Stanford Global Supply Chain Management Forum and the Center for Social Innovation at the Stanford Graduate School of Business.
Wal-Mart’s innovative approach to environmental sustainability and its addition of health care services to stores were partly triggered by critics of the company in other areas. CEO Lee Scott spoke with Sloan Fellows.
MBA students reflect on their service learning trip to India, where they met an extraordinary group of rural women who have changed the face of their village. These women helped to eradicate preventable disease while empowering themselves as major stakeholders in a community-driven revolution that has become more pervasive throughout the subcontinent.
Dr. Debrework Zewdie, director of the Global HIV/AIDS Program of the World Bank, speaks about mistakes in the fight against HIV/AIDS, highlighting an unfair distribution of medical treatments, a lack of prevention education, and the prominence of other, treatable diseases as reasons for the consistent difficulty fighting the epidemic.
America's health care system is broken, drug development takes too long and costs too much, and the FDA needs major reform, speakers told the annual Health Care and Biotech Symposium "5 by 20: Five Ideas That Will Revolutionize Health Care by 2020."
Step aside, Stephen Covey. Kent Buse and Andrew M. Harmer have discovered seven new highly effective habits. And theirs may help rid the world of its more deadly diseases, rather than just upping people’s productivity.
Recent neuroscience research confirms that people view drug addicts as not quite human.
Samantha King argues that the rise of philanthropy targeted at breast cancer has helped turn the disease from a political issue to a mainstream marketing gold mine. Review by Fran Visco
The MacArthur “genius” prize winner creates drugs for the developing world.
Larger social service organizations may result in less innovation.
Social media is helping people self-assemble for social action.
A look at how community advisory committees are faring in the health field.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
The question of what to eat to be healthy has spawned a rash of often contradictory advice by "experts." In this audio lecture, sponsored by the Stanford Ethics and Society Program, NYU professor and author Marion Nestle offers simple advice that cuts through the confusion. She highlights the difference between "nutrients" and "food," and suggests how to bring "nutrition" back into the food realm. Her discussion forays into how agriculture and business interact to produce the foodstuffs on our shelves.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
Q&A with Stefano Zenios on his new book, Biodesign: The Process of Innovating Medical Technologies.
A leukemia diagnosis for Sameer Bhatia is the start of a nation-wide project to create a bone marrow registry in India. Robert Chatwani describes one family's innovative effort to create social change and, in the process, find a perfect match for Sameer.
A leukemia diagnosis for Sameer Bhatia is the start of a nation-wide project to create a bone marrow registry in India. Robert Chatwani describes one family's innovative effort to create social change and, in the process, find a perfect match for Sameer.
A leukemia diagnosis for Sameer Bhatia is the start of a nation-wide project to create a bone marrow registry in India. Robert Chatwani describes one family's innovative effort to create social change and, in the process, find a perfect match for Sameer.
In the year 2000 DaVita, the largest independent provider of dialysis services in the United States, was being investigated by the SEC and sued by shareholders. Kent Thiry explains how building community bumped DaVita's market capitalization to $3 billion and turned it into a leader in its field.
Problem: the only remedy for morbid obesity is invasive surgery. Innovation: an oral device that reduces obesity without an incision.
"Innovation isn't about a point in time, it's about creating sustainable change over time," says Paul Wallace.
Government representatives and venture capitalists came together to hear Stanford student teams speak about the barriers that routinely prevent healthcare innovations from getting to market.
"No one has ever really designed the Intensive Care Unit," argues Dr. John D. Evans. Efficient technologies within the ICU are only half of the puzzle.
The Canary Fund supports the development of methods for early cancer detection. This second case presents the results of the sponsorship created to raise funding and awareness.
The Kinetics and Michael J. Fox Foundations both support research on Parkinson’s disease. This second case explores how these two organizations collaborate toward a common mission.
VaxGen is working to obtain approvals for phase III clinical trials in Thailand for an experimental vaccine against HIV. The company must cope with a host of ethical questions.
This case details the 2006 decision by the United Kingdom to deny coverage for a new form of inhaled insulin. In doing so, it highlights the challenges to innovators in managing conflicts over the costs, benefits, and risks of new technology.
In December 2004, the president of the Institute for Healthcare Improvement challenged U.S. hospitals to reduce unnecessary deaths by 100,000 in the next 18 months. The case describes a campaign that incorporated lessons from politics and social activism.
Gilead Sciences designs a strategy for delivering an AIDS drug to developing nations in Africa. This first part of the case describes the organization's initial considerations.
Gilead Sciences designs a strategy for delivering an AIDS drug to developing nations in Africa. This second part of the case explores the company’s experience with a distribution program.
Two social ventures collaborated with each other to help expand one’s solar energy services from southern Brazil into the Amazon region. The case highlights the core factors that led to the project’s ultimate outcome.
Riders for Health is a U.K.-based nonprofit dedicated to the improvement of transportation systems for health workers in Africa. In 2007, after 11 years in existence, the organization was at a critical point and had to decide what strategies were necessary to expand.
The Kinetics and Michael J. Fox Foundations both support research on Parkinson’s disease. This first case describes the creation, mission, and strategy of the two organizations.
Genzyme Tissue Repair had just received favorable phase I clinical trial results. Should the company go ahead with studies that would involve subjects in the placebo group having to undergo surgery but not receive the experimental transplants?
In 1999, Geron Corporation was at the center of the debate about human embryo research. The case details the controversy surrounding Geron’s stem cell research and the role the Ethics Advisory Board played in shaping the company's response.
Zeneca launched an ad campaign to promote a drug for use in reducing the risk of breast cancer. The case details the company’s development of the drug and its marketing efforts.
Two companies are competing to develop a genetic test for breast and ovarian cancer susceptibility. They must grapple with concerns about the ethics involved.
This note provides an overview of the role of employers, carriers, and consumers in the U.S. private health insurance market. It covers the history of employer-based coverage, employer decisions on health insurance, insurance pricing, and other topics.
Based on comparative case studies of Apple Computer’s strategic actions in the music and cellular telephone industries, this paper develops the concept of a “cross-boundary disruptor” as a new type of entrepreneurial actor in inter-industry strategic dynamics. It examines what kind of company could become a cross-boundary disruptor in the U.S. health care industry to help it overcome its long-standing stasis.
To identify the important tradeoffs in consulting a single expert for both diagnosis and treatment, the authors examine the costs and health outcomes of elderly Medicare beneficiaries with coronary artery disease.
In this paper, the authors calculate the consequences for health spending and the federal budget of an above-the-line deduction for out-of-pocket health spending. These estimates are compared to those of past researchers. Implications on tax policy are discussed.
This paper provides an analysis of the structure of the health care delivery system, emphasizing physician group practices. The authors argue for comprehensive integrated delivery systems (IDSs).
How can health officials, both in the public and private sector, ensure that their messages of prevention get heard? The studies conducted by Jennifer L. Aaker, the General Atlantic Professor of Marketing at the Stanford Graduate School of Business; Nidhi Agrawal of Northwestern University; and Geeta Menon of New York University suggest that an individual’s emotional state of mind affects how they cope with messages containing bad news about health risks. This suggests that individuals are more apt to accept negative health messages while watching humorous or “happy” programs.
The two-quarter Elective Course series provides lectures from a diverse group of faculty that expose students to the practical aspects of technology invention and development. The class features a presentation or discussion from one of the guest speakers or faculty. Students work in small project teams in the Biodesign prototyping lab or bench space, collaborating with the fellows of the program.
The purpose of this class is to provide students with the economic tools and the institutional and legal background to understand how markets for health care products and services work. The class utilizes case studies, lectures, and visits from individuals in the industry.
This course examines health care businesses and how they use technology (primarily biotechnology, medical technology, and information technology) to improve patient outcomes and manage costs. Through case studies, students gain an in-depth understanding of how new technologies get developed and commercialized in health care, and of how the whole health care value chain adapts to new technologies.
This course examines the application of cost-effectiveness and cost-benefit analysis, along with other evaluation techniques, to products and services such as medical care, whose "output" is difficult to measure. It critically reviews studies that apply cost analysis techniques to specific clinical problems.
Vision care is something that is practically taken for granted in the United States, but that’s not the case throughout much of the world. Some 300 million around the globe suffer from correctable vision loss, leading, as Ashanthi Mathai, MBA '04, says, “to people accepting their vision impairment and adjusting their lives around it.” The result? A lower quality of life, restricted job options, and even further economic distress.
Jane Chen's passion for helping others has taken her on an incredible journey from doing social work in China to founding Embrace, a company that sells premature infant incubators.
Caring for aging parents is a challenge many face, yet there is no clear path or pattern for how to manage this stage of life. Karen Routt shares her expertise at the nexus between technology and caring for the elderly.
With a high-tech background, an MBA, and an M.D., Dr. Patty Einarson has a unique perspective on the intersection of technology, business and medicine. She leverages this knowledge by contributing to math/science education in the public schools, encouraging the kids of today to become future innovators.
Mark Cafferty is passionate about empowering individuals to be all they can be. He channels funds to employment and youth service programs.
Using brain imaging and a video game, researchers teach girls at risk of depression how to train their brains away from negative situations.
Jane Chen's passion for helping others has taken her on an incredible journey from doing social work in China to founding Embrace, a company that sells premature infant incubators.
Caring for aging parents is a challenge many face, yet there is no clear path or pattern for how to manage this stage of life. Karen Routt shares her expertise at the nexus between technology and caring for the elderly.
Liberty and Justice, a for-profit, socially minded company, is creating jobs and improving health care for Liberian women
The United States has been a global leader to medical technology innovation, however a changing investment environment and tougher regulatory requirements prove unique challenges for early stage innovators. From the 2011 Stanford Graduate School of Business Healthcare Summit, Stefanos Zenios, director of Stanford's GSB Program in Healthcare Innovation convenes a panel of health care investors who give those entrepreneurs starting out a full picture of the product development cycle and how to successfully raise capital.
You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.